Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center
暂无分享,去创建一个
A. Ferrari | M. Massimino | P. Gasparini | R. Luksch | C. Meazza | F. Spreafico | M. Podda | M. Terenziani | M. Casanova | E. Schiavello | N. Puma | V. Biassoni | S. Chiaravalli | L. Bergamaschi | E. Pecori | O. Alessandro | G. Gattuso | V. Livellara | G. Sironi | O. Nigro
[1] S. Bielack,et al. Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS) , 2021, Pediatric blood & cancer.
[2] S. Ferrari,et al. Efficacy of dose intensification in induction therapy for localized Ewing sarcoma: Italian Sarcoma Group (ISG) and Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP) ISG/AIEOP EW-1 study. , 2021 .
[3] A. Tawil,et al. Extraskeletal Ewing sarcoma: Diagnosis, management and prognosis. , 2021, Oncology letters.
[4] A. Lazar,et al. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. , 2020, The oncologist.
[5] H. Gelderblom,et al. Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012). , 2020 .
[6] U. Dirksen,et al. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] S. Salah,et al. Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol , 2019, Clinical and Translational Oncology.
[8] P. Houghton,et al. Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force , 2019, F1000Research.
[9] A. Schuck,et al. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS‐81, ‐86, ‐91, ‐96, and ‐2002P trials , 2018, Pediatric blood & cancer.
[10] J. Blay,et al. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Andrew D. Lynch,et al. Extraskeletal versus Skeletal Ewing Sarcoma in the adult population: Controversies in care. , 2018, Surgical oncology.
[12] M. Stevens,et al. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. , 2018, The Lancet. Oncology.
[13] W. Harmsen,et al. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. , 2017, International journal of radiation oncology, biology, physics.
[14] S. Lessnick,et al. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group , 2015, Pediatric blood & cancer.
[15] H. Yoshikawa,et al. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma. , 2016, Japanese journal of clinical oncology.
[16] P. Houghton,et al. The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma , 2015, Genes & cancer.
[17] U. Dirksen,et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] S. Donaldson,et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group , 2015, Cancer.
[19] U. Dirksen,et al. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] S. Talole,et al. Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin , 2013, Pediatric Surgery International.
[21] M. Eriksson,et al. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. , 2012 .
[22] A. Davidoff,et al. Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children’s Research Hospital Experience , 2012, Annals of Surgical Oncology.
[23] H. Turna,et al. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome. , 2012, Japanese journal of clinical oncology.
[24] J. Neuhaus,et al. Clinical features and outcomes in patients with extraskeletal ewing sarcoma , 2011, Cancer.
[25] D. Peake,et al. Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma? , 2011, The Journal of bone and joint surgery. British volume.
[26] U. Dirksen,et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Bazarbashi,et al. Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[28] Hendrik van den Berg,et al. EXTRA-OSSEOUS EWING SARCOMA , 2009, Pediatric hematology and oncology.
[29] T. Triche,et al. Extraosseous Ewing's sarcoma: 25 years later. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] O. Delattre,et al. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] P. Terrier,et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] A. Ferrari,et al. Localized unresectable non‐rhabdo soft tissue sarcomas of the extremities in pediatric age , 2005, Cancer.
[33] S. Todo,et al. [TNM classification--pediatric tumors]. , 1998, Gan to kagaku ryoho. Cancer & chemotherapy.
[34] James R. Anderson,et al. Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] E. Gehan,et al. The intergroup rhabdomyosarcoma study‐I. A final report , 1988, Cancer.
[36] A. Cabrera,et al. EWING'S SARCOMA. , 1964, Surgery, gynecology & obstetrics.
[37] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[38] M. Figari,et al. [Extraosseous Ewing sarcoma]. , 2019, Medicina.
[39] M. Link,et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] W. Winkelmann,et al. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.